Syncope Secondary to Arrhythmogenic Left Ventricular Cardiomyopathy: a Case Report

Overview

Journal AME Case Rep

Publisher AME Publishing Company

Date 2025 Jan 27

PMID 39866274

Authors

Jing Lin

Qingwei Ji

Ling Liu

Zongyan Huang

Yingxia Yang

Jie Shen

Affiliations

Soon will be listed here.

Abstract

Background: Arrhythmogenic cardiomyopathy (ACM) is an inherited cardiac disease characterized by fibrofatty replacement of ventricular myocardium. Ventricular arrhythmia and sudden cardiac death (SCD) are the main clinical manifestations. ACM was previously called arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D). However, recent studies have shown that this disease is not limited to the right ventricle; biventricular involvement occurs in 50% of ACM patients. The left-dominant subtype was subsequently identified, which supported the adoption of the broader term "ACM". The clinical literature includes more extensive reports on ARVC, but reports on arrhythmogenic left ventricular cardiomyopathy (ALVC), which is likely to be underrecognized, are limited.

Case Description: In this report, we describe a case of secondary syncope in a patient with ALVC who developed right bundle branch block with ventricular tachycardia (RBBB-VT), with VT originating in the left ventricle (LV). Cardiac magnetic resonance (CMR) revealed significant enlargement of the LV, with LV dysfunction. Late gadolinium enhancement (LGE) and fat sequencing revealed that most of the free wall of the LV was replaced by fibrofatty tissue.

Conclusions: This report could help improve the understanding of this rare disease, and its management. CMR plays a key role in the diagnosis of ACM.

References

Costa S, Cerrone M, Saguner A, Brunckhorst C, Delmar M, Duru F . Arrhythmogenic cardiomyopathy: An in-depth look at molecular mechanisms and clinical correlates. Trends Cardiovasc Med. 2020; 31(7):395-402. DOI: 10.1016/j.tcm.2020.07.006. View

Ye J, Delmar M, Lundby A, S Olesen M . Reevaluation of genetic variants previously associated with arrhythmogenic right ventricular cardiomyopathy integrating population-based cohorts and proteomics data. Clin Genet. 2019; 96(6):506-514. DOI: 10.1111/cge.13621. View

Miles C, Finocchiaro G, Papadakis M, Gray B, Westaby J, Ensam B . Sudden Death and Left Ventricular Involvement in Arrhythmogenic Cardiomyopathy. Circulation. 2019; 139(15):1786-1797. PMC: 6467560. DOI: 10.1161/CIRCULATIONAHA.118.037230. View

Gandjbakhch E, Redheuil A, Pousset F, Charron P, Frank R . Clinical Diagnosis, Imaging, and Genetics of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: JACC State-of-the-Art Review. J Am Coll Cardiol. 2018; 72(7):784-804. DOI: 10.1016/j.jacc.2018.05.065. View

Bennett R, Haqqani H, Berruezo A, Della Bella P, Marchlinski F, Hsu C . Arrhythmogenic Cardiomyopathy in 2018-2019: ARVC/ALVC or Both?. Heart Lung Circ. 2018; 28(1):164-177. DOI: 10.1016/j.hlc.2018.10.013. View

Segura-Rodriguez D, Bermudez-Jimenez F, Carriel V, Lopez-Fernandez S, Gonzalez-Molina M, Oyonarte Ramirez J . Myocardial fibrosis in arrhythmogenic cardiomyopathy: a genotype-phenotype correlation study. Eur Heart J Cardiovasc Imaging. 2019; 21(4):378-386. DOI: 10.1093/ehjci/jez277. View

Aquaro G, De Luca A, Cappelletto C, Raimondi F, Bianco F, Botto N . Prognostic Value of Magnetic Resonance Phenotype in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy. J Am Coll Cardiol. 2020; 75(22):2753-2765. DOI: 10.1016/j.jacc.2020.04.023. View

Towbin J, McKenna W, Abrams D, Ackerman M, Calkins H, Darrieux F . 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy: Executive summary. Heart Rhythm. 2019; 16(11):e373-e407. DOI: 10.1016/j.hrthm.2019.09.019. View

Duru F, Hauer R . Multiple facets of arrhythmogenic cardiomyopathy: the Fuwai classification of a unique disease based on clinical features, histopathology, and genotype. Eur Heart J. 2019; 40(21):1704-1706. DOI: 10.1093/eurheartj/ehz253. View

10.

Desai Y, Parikh V . Genetic Risk Stratification in Arrhythmogenic Left Ventricular Cardiomyopathy. Card Electrophysiol Clin. 2023; 15(3):391-399. DOI: 10.1016/j.ccep.2023.04.005. View

11.

Arbelo E, Protonotarios A, Gimeno J, Arbustini E, Barriales-Villa R, Basso C . 2023 ESC Guidelines for the management of cardiomyopathies. Eur Heart J. 2023; 44(37):3503-3626. DOI: 10.1093/eurheartj/ehad194. View

12.

Marcus F, McKenna W, Sherrill D, Basso C, Bauce B, Bluemke D . Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation. 2010; 121(13):1533-41. PMC: 2860804. DOI: 10.1161/CIRCULATIONAHA.108.840827. View

13.

Chen L, Song J, Chen X, Chen K, Ren J, Zhang N . A novel genotype-based clinicopathology classification of arrhythmogenic cardiomyopathy provides novel insights into disease progression. Eur Heart J. 2019; 40(21):1690-1703. DOI: 10.1093/eurheartj/ehz172. View

14.

Corrado D, Perazzolo Marra M, Zorzi A, Beffagna G, Cipriani A, De Lazzari M . Diagnosis of arrhythmogenic cardiomyopathy: The Padua criteria. Int J Cardiol. 2020; 319:106-114. DOI: 10.1016/j.ijcard.2020.06.005. View

15.

Mattesi G, Cipriani A, Bauce B, Rigato I, Zorzi A, Corrado D . Arrhythmogenic Left Ventricular Cardiomyopathy: Genotype-Phenotype Correlations and New Diagnostic Criteria. J Clin Med. 2021; 10(10). PMC: 8160676. DOI: 10.3390/jcm10102212. View

16.

Murray B, Tandri H . Arrhythmogenic cardiomyopathy: genotype-first diagnosis. Eur Heart J Cardiovasc Imaging. 2020; 21(4):387-388. DOI: 10.1093/ehjci/jez313. View

17.

Bariani R, Rigato I, Cason M, Bueno Marinas M, Celeghin R, Pilichou K . Genetic Background and Clinical Features in Arrhythmogenic Left Ventricular Cardiomyopathy: A Systematic Review. J Clin Med. 2022; 11(15). PMC: 9332695. DOI: 10.3390/jcm11154313. View

18.

Vives-Gilabert Y, Sanz-Sanchez J, Molina P, Cebrian A, Igual B, Calvillo-Batlles P . Left ventricular myocardial dysfunction in arrhythmogenic cardiomyopathy with left ventricular involvement: A door to improving diagnosis. Int J Cardiol. 2018; 274:237-244. DOI: 10.1016/j.ijcard.2018.09.024. View